Duality Advisers, LP Dexcom Inc Transaction History

Duality Advisers, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$75.49 - $124.16 $3.12 Million - $5.13 Million	41,321 New	41,321 $5.13 Million
Q2 2023 Jul 31, 2023	BUY	$112.47 - $130.98 $1.19 Million - $1.38 Million	10,562 New	10,562 $1.36 Million
Q4 2022 Feb 07, 2023	BUY	$84.98 - $122.67 $2.92 Million - $4.21 Million	34,337 New	34,337 $3.89 Million
Q1 2022 May 09, 2022	SELL	$94.08 - $130.2 $123,997 - $171,603	-1,318 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$129.87 - $162.82 $171,168 - $214,596	1,318 New	1,318 $708,000
Q3 2021 Nov 08, 2021	SELL	$106.71 - $143.18 $656,266 - $880,557	-6,150 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$80.99 - $107.93 $412,644 - $549,903	5,095 Added 482.94%	6,150 $2.63 Million
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $10,344 - $12,778	122 Added 13.08%	1,055 $379,000
Q4 2020 Feb 09, 2021	SELL	$78.0 - $104.5 $10,686 - $14,316	-137 Reduced 12.8%	933 $345,000
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $102,195 - $120,856	1,070 New	1,070 $441,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.